StonvexLoading…
StonvexStonvexStonvexCore line items from PRMB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.63B | $6.66B | $5.11B | $3.34B |
Operating Income | $138.00M | $430.40M | $412.40M | $266.00M |
Net Income | $27.30M | $60.10M | $73.10M | $56.30M |
EPS (Diluted) | $0.07 | $0.16 | $0.19 | $0.15 |
Total Assets | $10.59B | $10.60B | $10.96B | $11.05B |
Total Liabilities | $7.63B | $7.61B | $7.80B | $7.80B |
Cash & Equivalents | $288.20M | $376.70M | $422.70M | $412.00M |
Free Cash Flow OCF − CapEx | $-700.00K | $302.90M | $245.60M | $77.90M |
Shares Outstanding | 362.93M | 363.94M | 370.62M | 373.34M |